NTAGI allows 1st dose as booster for those vaccinated with Sputnik: Report

Currently, there is no policy decision on providing a precaution dose to those inoculated with the Russian vaccine

vaccine, covid, corona, coronavirus
A healthcare worker administers a dose of Covid-19 preventive vaccine to an elderly person, in New Delhi, Saturday, April 23, 2022. (PTI Photo/Shahbaz Khan)
Press Trust of India New Delhi
2 min read Last Updated : Apr 30 2022 | 8:01 PM IST

The first dose of Sputnik V vaccine can be administered as the precaution dose to all those vaccinated with the Russian COVID-19 jab, an NTAGI panel has recommended, official sources told PTI on Saturday.

The two doses of Sputnik V vaccine have separate compositions.

Currently, there is no policy decision on providing a precaution dose to those inoculated with the Russian vaccine.

The CoWIN portal does not show the option of precaution dose for Sputnik V.

Many Sputnik V recipients who had taken their second dose way back in July last year are unable to get the booster shot.

The two doses of Sputnik V are administered at a gap of 21-30 days.

The first dose of the vaccine contains a recombinant adenovirus type 26 (rAd26-S) and the second dose a recombinant adenovirus 5 (rAd5-S), an official explained.

"The NTAGI's Standing Technical Sub-Committee (STSC) which held its meeting on Friday discussed the issue and recommended that Sputnik Light which has the same component of Sputnik V's first dose will be given as the precaution dose," a official source told PTI.

The National Technical Advisory Group on Immunisation (NTAGI) is an advisory committee comprising multidisciplinary experts responsible for providing information and recommendations to government for making evidence-based decisions regarding vaccine and immunisation policy.

The Union Health Ministry is learnt to have received several representations over the precaution dose of Sputnik V.

According to sources, more than six lakh people have received the Russian vaccine.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccine

First Published: Apr 30 2022 | 7:46 PM IST

Next Story